Oxford Pharmascience Group plc is a specialist pharmaceutical technology company. The Company is engaged in developing and licensing solutions to add value to off patent drugs. Its technology portfolio includes delivery systems for liquid suspensions, solid state suspensions (soft chews) and chewable tablets, and technologies OXP zero which allows for taste masking and OXP target which allows for precise drug delivery. Its taste masking technology can be incorporated into other 3rd party development systems where taste or dissolution is an issue, as well as in its own delivery systems. Its products include OXP zero Ibuprofen and OXP chew Calcium and Vitamin D. The Company operates in four main geographic areas : the United Kingdom, Middle East, Brazil and Far East. Its subsidiaries include Oxford Pharmascience Limited and Oxford Nutra Limited.